108 Results (Page 1 of 9)
Australia Markets Research Reports
Australia Diabetes Devices Market Analysis
The Australian Diabetes Devices Market is expected to witness growth from $273 Mn in 2022 to $532 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. In Australia, the market for diabetes devices is expanding as a result of the rise in the number of people with the condition and the demand for diabetes devices that can assist people in managing their condition. The market is segmented by type and by the end user. Some key players in this market include Fairmont Medical Products, Cook Medical Australia, Johnson & Johnson, Medtronic, Roche, Ascensia diabetes care and Dexcom.
Australia Cardiac Surgery Instruments Market Analysis
The Australian Cardiac Surgery Instruments Market is expected to witness growth from $25 Mn in 2022 to $46 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Australia, the demand for minimally invasive surgical instruments, like endoscopes and laparoscopic instruments, is anticipated to increase in the Australian healthcare market as patients there seek out less invasive surgical choices that reduce scarring and recovery time. The market is segmented by type, application and by end user. Some key players in this market include Fairmont Medical Products, Rowe Medical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Australia Cardiovascular Diseases Therapeutics Market Analysis
Australia's cardiovascular disease therapeutics market is expected to witness growth from $1.95 Bn in 2022 to $3.81 Bn in 2030 with a CAGR of 8.72% for the year 2022-2030. The rising prevalence of cardiovascular diseases and the demand for innovative therapeutic options for treatment in Australia is responsible for the expansion of the market. The Australia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Folarix Pharmaceutical, Adelco Pharmaceuticals, and AstraZeneca are the major players in the Australia cardiovascular disease therapeutics market.
Australia Anti Aging Therapeutics Market Analysis
Australia anti-aging therapeutics market is projected to grow from $7 Mn in 2022 to $27 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The increasing elderly population and innovative technological advancements in Australia are responsible for the growth of the market. The Australia anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Clinuvel Pharmaceuticals, EZZ Life Science, and PharmatrophiX are the major competitors in the market.
Australia Artificial Intelligence (AI) in Healthcare Market Analysis
Australia's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.08 Bn in 2022 to $1.78 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022-30. The market will be driven by the increasing demand for efficient and effective healthcare delivery and the availability of healthcare data. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, HealthMatch & Clevertar.
Australia Biosimilars Market Analysis
The Australia Biosimilars market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.7% from 2022 to 2030 and will reach $1263 Mn in 2030. The market is segmented by product type and indication type. The Australian Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait for times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.
Australia Healthcare Financial Analytics Market Analysis
The Australia Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Australia’s Healthcare Financial Analytics market will grow as the rising cost of healthcare in Australia is driving the need for financial analytics solutions that can help healthcare organizations manage and optimize their spending. The key market players are ClinTrial Refer, Advantech, HotDoc, Health Metrics, IQVIA, and others.
Australia Healthcare Insurance Market Analysis
The Australian healthcare insurance market is projected to grow from $24.31 Bn in 2022 to $48.81 Bn by 2030, registering a CAGR of 9.1% during the forecast period of 2022 - 2030. The main factors driving the growth would be government policies, increasing awareness, rising healthcare costs and the growing geriatric population. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Pheonix Health fund, NIB, HBF, St. Lukes's and Latrobe.
Australia Healthcare Claims Management Market Analysis
The Australian healthcare claims management market is projected to grow from $320.4 Mn in 2022 to $1897.54 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in healthcare provider consolidation, technological advancements, regulatory changes and an increase in healthcare spending. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Proclaim, Medibank, Riskware, Cognizant and Accenture.
Australia Diagnostic Imaging Services Market Analysis
The Australia Diagnostic Imaging Services market size was valued at $6.3 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $10.3 Bn in 2030. The market is segmented by product, application, and end user. The Australia Diagnostic Imaging Services market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited (AUS), I-MED Radiology Network (AUS), Capitol Health Limited (AUS), Integral Diagnostics Limited (AUS), and others.
Australia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Australia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Liver Disease Therapeutics market will reach a value of $483 Mn from $277 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare Australia, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Australia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Australian Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Australia Home Healthcare Market Analysis
The Australia Home Healthcare Market is projected to grow from $4.3 Bn in 2022 to $8.9 Bn by 2030, registering a CAGR of 9.43% during the forecast period of 2022 - 2030. Because of the rising older population and the increasing number of people motivated to fight ailments including heart problems, diabetes, and various respiratory illnesses, the Australia home healthcare market is expanding at a promising CAGR. The market is segmented by solution, by deployment, and by end-use. There are a number of private companies that provide home healthcare services in Australia, including Bupa, NIB Health Funds, and HCF.
Australia Digital Health Market Analysis
The Australia digital health market was valued at $2.5 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.10% from 2022 to 2030 and will reach $10.96 Bn in 2030. One of the main reasons propelling the growth of this market is rising smartphone adoption, improved internet connectivity, and improved healthcare. The market is segmented by product, by end-user, and by component. Some key players in this market are Alcidion Corp., Doctors on Demand Pty Ltd, Ellume Limited, Genie Solutions Pty Ltd, and Harrison-Al Pty Ltd.
Australia Oncology Clinical Trials Market Analysis
Australia's oncology clinical trials market is projected to grow from $151.8 Mn in 2022 to $260.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the rising investment in clinical research, increased patient education and engagement, and the development of new and innovative clinical trial designs. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, AstraZeneca plc & Kazia Therapeutics Limited.
Australia Oral Care Market Analysis
The Australia Oral Care market was valued at $423 Mn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $765 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing Disposable Income, aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are White Glo, Grants of Australia, Red Seal, Dr. Brite, Pure Smile among others.
Australia Multiple Myeloma Therapeutics Market Analysis
The Australia Multiple Myeloma Therapeutics Market was valued at $100 Mn in 2022 and is estimated to expand at a CAGR of 6% from 2022 to 2030 and will reach $160 Mn in 2030. One of the main reasons propelling the growth of this Market is Increasing healthcare expenditure, Increasing geriatric population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are CSL, Telix Pharmaceuticals, Mesoblast, Kazia Therapeutics, Immutep, Patrys, Actinogen Medical, Noxopharm, Prima BioMed, Polynovo and others.
Australia Diabetes Drugs Market Analysis
The Australia diabetes drugs market size was valued at $0.74 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030 and will reach $1.33 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Australia diabetes drug market will grow because of the high prevalence of diabetes in the country, which creates a significant demand for medications to manage the disease. The key market players are CSL Limited, AstraZeneca, Novo Nordisk, Sanofi, and others.
Australia Alexipharmic Drugs Market Analysis
Australia's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The rising incidence of poisonings due to accidental or intentional exposure to toxins is driving the demand for alexipharmic drugs in Australia. The key market players are CSL Behring, Hospira, Mylan, Phebra (AUS), and others.
Australia Connected Healthcare Market Analysis
The Australia-connected healthcare market is projected to grow from $796.32 Mn in 2022 to $6444.96 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising geriatric population, geographic challenges, technological innovation and government investment. The market is segmented by type, function and by application. Some of the major players include Telstra Health, HealthEngine, ResApp, MyHealth1st, Apple, IBM and Microsoft.
Australia Artificial Intelligence (AI) in Medical Imaging Market Analysis
Australia artificial intelligence (AI) in medical Imaging market size was valued at $18 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $222 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to rowing demand for advanced healthcare solutions, the demand for AI in medical imaging is rising across the Australia market. Some of the key players in this market are Harrison.ai (AUS), MaxQ AI (AUS), LBT Innovations (AUS), 4Dx Limited (AUS), Oneview Healthcare (AUS), Siemens Healthineers, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems Australia, and others.
Australia Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Australia Primary Hyperoxaluria (PH) Therapeutics market was valued at $2.1 Bn in 2022 and is estimated to expand at a CAGR of 19% from 2022 to 2030 and will reach $8.8 Bn in 2030. One of the main reasons propelling the growth of this market is Increasing awareness about rare and genetic disorders, Increase in the clinical trial activity. The market is segmented by diagnostic method, by treatment, by type. Some key players in this market are Biocodex, Chinook Therapeutics, Bridgebio Pharma, BioMarin Pharmaceuticals, Amarna Therapeutics and among others.
Australia Neurology Clinical Trials Market Analysis
The Australia Neurology Clinical Trials market is projected to grow from $62.8 Mn in 2022 to $107.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by internationally competitive government subsidies for R&D investment and a well-developed infrastructure to support clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc, Neuroscience Trials Australia & Prana Biotechnology Limited.
Australia 3D Printing Medical Devices Market Analysis
The Australia 3D Printing Medical Devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as the 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Strykerand others.
Australia Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The Australia COPD Therapeutics Market was valued at $219 Mn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $424 Mn in 2030. One of the main reasons propelling the growth of this market is Technological advancements, increasing awareness. The market is segmented by Drug class and By distribution channel. Some key players in this market are F. Hoffmann-La Roche, Mylan N.V, Merck & Co, Vectura Group, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Australia Limited and others.